Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Clin J Pain. 2023 Feb 1;39(2):76–84. doi: 10.1097/AJP.0000000000001090

Table 4:

Univariable GEE analysis of baseline variables and PROMIS sleep disturbance across 4 time points (baseline, 2 weeks, 6 months, and 12 months)

Baseline Variable B (CI) SE Test Statistic p
Univariable GEE
Sociodemographics
 Age −0.15 (−0.21, −0.09) 0.03 22.26 <.001
 Education −0.78 (−1.45, −.011) 0.34 5.21 .022
 Non-Caucasian −0.61 (−3.31, 2.10) 1.38 0.19 .661
Surgical Variables
 Surgery/reconstruction type
  Breast conserving surgery (Lumpectomy) Ref Ref Ref Ref
  Mastectomy −0.95 (−3.40, 1.49) 1.25 0.59 .444
  Mastectomy with reconstruction 1.70 (−0.06, 3.45) 0.90 3.59 .058
  Axillary procedure 3.65 (1.42, 5.88) 1.14 10.30 .001
Treatment variables
 Radiation therapy −0.62 (−2.22, 0.99) 0.82 0.57 .451
 Chemotherapy* 1.70 (0.03, 3.33) 0.84 3.98 .046
Breast Cancer Pain questionnaire (BCPQ)
 Pain Severity Index (PSI) 0.22 (0.10, 0.35) 0.06 11.87 .001
 Opioid use 4.97 ( 2.19, 7.74) 1.42 12.31 <.001
Psychological Variables
 Pain Catastrophizing 0.25 (0.13, 0.37) 0.06 15.66 <.001
 Anxiety (PROMIS-SF) 0.49 (0.34, 0.65) 0.08 40.20 <.001
 Depression (PROMIS-SF) 0.45 (0.26, 0.65) 0.10 21.46 <.001
 Negative Affect (PANAS) 0.35 (0.19, 0.50) 0.08 18.23 <.001
 Positive Affect (PANAS) −0.26 (−0.38, −0.15) 0.06 20.41 <.001
 Somatization (BSI) 0.89 (00.50, 1.27) 0.20 20.65 <.001